Takeda Pharmaceutical Co Ltd
(SSE:4502)
円
4300
0 (0%)
Market Cap: 6.31 Til
Enterprise Value: 10.68 Til
PE Ratio: 44.29
PB Ratio: 0.87
GF Score: 80/100 - Q3 2024 Takeda Pharmaceutical Co Ltd Earnings Presentation TranscriptFeb 01, 2024
- Takeda Pharmaceutical Co Ltd at JPMorgan Healthcare Conference TranscriptJan 09, 2024
- Q2 2024 Takeda Pharmaceutical Co Ltd Earnings Presentation TranscriptOct 26, 2023
- Takeda Pharmaceutical Co Ltd at Morgan Stanley Global Healthcare Conference TranscriptSep 11, 2023
- Q1 2024 Takeda Pharmaceutical Co Ltd Earnings Presentation TranscriptJul 27, 2023
- Full Year 2023 Takeda Pharmaceutical Co Ltd Earnings Presentation TranscriptMay 11, 2023
- Takeda Pharmaceutical Co Ltd TAK-279 on Phase 2b Psoriasis Investor Call TranscriptMar 18, 2023
- Takeda Pharmaceutical Co Ltd QDENGA Investor Call TranscriptMar 15, 2023
- Takeda Pharmaceutical Co Ltd at Cowen Health Care Conference TranscriptMar 06, 2023
- Q3 2023 Takeda Pharmaceutical Co Ltd Earnings Presentation TranscriptFeb 02, 2023
- Takeda Pharmaceutical Co Ltd at JPMorgan Healthcare Conference TranscriptJan 10, 2023
- Takeda Pharmaceutical Co Ltd to Acquire Oral Allosteric TYK2 Inhibitor NDI-034858 From Nimbus Therapeutics Call TranscriptDec 13, 2022
- Q2 2023 Takeda Pharmaceutical Co Ltd Earnings Presentation TranscriptOct 27, 2022
- Takeda Pharmaceutical Co Ltd Lysosomal Storage Diseases Investor Seminar TranscriptOct 04, 2022
- Takeda Pharmaceutical Co Ltd at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2022
- Q1 2023 Takeda Pharmaceutical Co Ltd Earnings Call TranscriptJul 28, 2022円3625Earnings
- Full Year 2022 Takeda Pharmaceutical Co Ltd Earnings Presentation (Q&A) TranscriptMay 11, 2022
- Full Year 2022 Takeda Pharmaceutical Co Ltd Earnings Presentation TranscriptMay 11, 2022
- Takeda Pharmaceutical Co Ltd at Cowen Health Care Conference (Virtual) TranscriptMar 08, 2022
- Q3 2022 Takeda Pharmaceutical Co Ltd Earnings Call TranscriptFeb 03, 2022円3315Earnings
- Takeda Pharmaceutical Co Ltd at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2022
- Takeda Pharmaceutical Co Ltd Management Call TranscriptJan 10, 2022
- Takeda Pharmaceutical Co Ltd Plasma-Derived Therapies Investor Event Presentation (Japanese) TranscriptNov 17, 2021
- Q2 2022 Takeda Pharmaceutical Co Ltd Earnings Call TranscriptOct 28, 2021円3220Earnings
- Q2 2022 Takeda Pharmaceutical Co Ltd Earnings Press Conference TranscriptOct 28, 2021
- Calithera Biosciences Inc to Acquire Assets From Takeda Pharmaceutical Co Ltd Call TranscriptOct 18, 2021
- Q1 2022 Takeda Pharmaceutical Co Ltd Earnings Call TranscriptJul 30, 2021円3800Earnings
- Takeda Pharmaceutical Co Ltd Finance Investor Day TranscriptJul 12, 2021
- Takeda Pharmaceutical Co Ltd Oncology Strategic Update Call TranscriptJun 08, 2021
- Full Year 2021 Takeda Pharmaceutical Co Ltd Earnings Call - Q&A Session TranscriptMay 11, 2021円3955Earnings
- Full Year 2021 Takeda Pharmaceutical Co Ltd Earnings Call TranscriptMay 11, 2021円3955Earnings
- Full Year 2021 Takeda Pharmaceutical Co Ltd Earnings Press Conference TranscriptMay 11, 2021
- Takeda Pharmaceutical Co Ltd Wave 1 Pipeline Opportunity Call - Part 2 - R&D Team Follow Up Call TranscriptApr 21, 2021
- Takeda Pharmaceutical Co Ltd Wave 1 Pipeline Opportunity Call - Part 2 TranscriptApr 06, 2021
- Takeda Pharmaceutical Co Ltd Growth & Emerging Markets Strategic Update Call TranscriptMar 11, 2021
- Ovid Therapeutics Inc and Takeda Pharmaceutical Co Ltd to Discuss Strategic Transaction Call TranscriptMar 03, 2021
- Takeda Pharmaceutical Co Ltd Oncology Business Investor and Analyst Seminar TranscriptFeb 25, 2021
- Q3 2021 Takeda Pharmaceutical Co Ltd Earnings Call TranscriptFeb 04, 2021円3620Earnings
- Takeda Pharmaceutical Co Ltd World Conference on Lung Cancer (WCLC) Investor Call TranscriptJan 29, 2021
- Takeda Pharmaceutical Co Ltd at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2021
- Takeda Pharmaceutical Co Ltd Wave 1 Pipeline Market Opportunity Call TranscriptDec 08, 2020
- Q2 2021 Takeda Pharmaceutical Co Ltd Earnings Call - Q&A Session TranscriptOct 29, 2020円3590Earnings
- Q2 2021 Takeda Pharmaceutical Co Ltd Earnings Call TranscriptOct 29, 2020円3590Earnings
- Arrowhead Pharmaceuticals Inc and Takeda Pharmaceutical Co Ltd Collaboration and Licensing Agreement to Develop ARO-AAT Conference Call TranscriptOct 08, 2020
- Ovid Therapeutics Inc. - Special Call TranscriptAug 25, 2020
- Q1 2021 Takeda Pharmaceutical Co Ltd Earnings Call - Q&A Session TranscriptJul 31, 2020円3800 (-6.17%)Earnings
- Q1 2021 Takeda Pharmaceutical Co Ltd Earnings Call TranscriptJul 31, 2020円3800 (-6.17%)Earnings
- Neurocrine Biosciences Inc and Takeda Pharmaceutical Co Ltd Announce Collaboration to Develop and Commercialize Potential Therapies for Psychiatric Disorders TranscriptJun 16, 2020
- Takeda Pharmaceutical Co Ltd Oncology Focused Investor Call TranscriptJun 08, 2020
- Takeda Pharmaceutical Co Ltd at Jefferies Healthcare Conference (Virtual) TranscriptJun 02, 2020
- Full Year 2020 Takeda Pharmaceutical Co Ltd Earnings Call - Q&A Session TranscriptMay 13, 2020円3670Earnings
- Full Year 2020 Takeda Pharmaceutical Co Ltd Earnings Call TranscriptMay 13, 2020円3670Earnings
- Q3 2020 Takeda Pharmaceutical Co Ltd Earnings Call - Q&A Session TranscriptFeb 04, 2020円4415Earnings
- Q3 2020 Takeda Pharmaceutical Co Ltd Earnings Call TranscriptFeb 04, 2020円4415Earnings
- Takeda Pharmaceutical Co Ltd at JPMorgan Healthcare Conference TranscriptJan 15, 2020
- Takeda Pharmaceutical Co Ltd R&D and Plasma-Derived Therapies Day - Tokyo TranscriptNov 21, 2019
- Takeda Pharmaceutical Co Ltd Plasma-Derived Therapies Day - Georgia TranscriptNov 15, 2019
- Takeda Pharmaceutical Co Ltd R&D Day - New York TranscriptNov 14, 2019
- Q2 2020 Takeda Pharmaceutical Co Ltd Earnings Call TranscriptOct 31, 2019円3760Earnings
- Q2 2020 Takeda Pharmaceutical Co Ltd Earnings Presentation TranscriptOct 31, 2019
- Takeda Pharmaceutical Co Ltd Plasma-Derived Therapies Business Investor Meeting TranscriptOct 10, 2019
- Takeda Pharmaceutical Co Ltd at Morgan Stanley Healthcare Conference TranscriptSep 10, 2019
- Q1 2020 Takeda Pharmaceutical Co Ltd Earnings Call TranscriptJul 31, 2019円3890Earnings
- Full Year 2019 Takeda Pharmaceutical Co Ltd Earnings Call TranscriptMay 14, 2019円4250 (-1.85%)Earnings
- Full Year 2019 Takeda Pharmaceutical Co Ltd Earnings Call TranscriptMay 14, 2019円4250 (-1.85%)Earnings
- Novartis AG to Discuss Acquisition of Xiidra® from Takeda Pharmaceutical Co Ltd Call TranscriptMay 09, 2019
Q2 2020 Takeda Pharmaceutical Co Ltd Earnings Presentation Transcript
Oct 31, 2019 / 08:45AM GMT
Release Date Price:
円3760
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)